Feature Story | 6-Jun-2023

10 years of epigenetic aging research: Simple interventions to slow down epigenetic aging

Deep Longevity Ltd

Deep Longevity, which has been at the forefront of aging clock research for several years, in collaboration with researchers from the University of Lethbridge, Buck Institute , Insilico Medicine, and Shanghai Cancer Institute, has published a review in the leading peer-reviewed scientific journal, National Library of Medicine. The paper titled "Stress, Diet Exercise: Common Environmental Factors and Their Impact on Epigenetic Age" reviews the latest developments in epigenetic aging clock technology, including the use of DNA methylation patterns to predict biological age, and highlights the potential of currently available and practical interventions to slow down the aging process. 

It has been 10 years since the first multi-tissue epigenetic aging clock was published in 2013 by Steve Horvath. In their article, the researchers reviewed the immense research which has taken place in the past years to summarize the contributions of common environmental factors on the pace of aging.   

The review paper also assesses the rejuvenating potential of various small drug interventions, as well as their limitations in pharmaceutical use today due to a  shortage of clinical trials implementing epigenetic aging clocks.  


The review paper has been well-received by the scientific community and   contributes to the ongoing discussion regarding the impact of anti-aging research on everyday life. It provides a comprehensive overview of the latest developments in epigenetic aging clock technology and offers practical tips for individuals looking to improve their health and extend their lifespan. 


" We are thrilled by the interest in our research and look forward to raising awareness about the potential of epigenetic aging clocks, enabling everyone to utilize a wide variety of aging clocks available via the platform we have built ." explains Fedor Galkin, the Chief Scientist of Deep Longevity. 


It is to be noted that Deep Longevity has successfully created its own epigenetic aging clock, which will be integrated and hosted within the SenoClock SaaS platform. They are also collaborating with other researchers in the field to further advance the technology and explore new applications and unforeseen use cases of their technology. The team has expressed their excitement about the potential of their epigenetic aging clock to help individuals transcend the current human healthspan and lifespan. 

"We are committed to advancing the field of epigenetic aging clocks and are constantly looking for new ways to improve our technology," Deepankar Nayak, the CEO of Deep Longevity, mentioned talking about their current research and future plans, "We believe that our work has the potential to revolutionize the way we approach aging and health, and we are excited to be at the forefront of this exciting field." 


As we reflect on the immense progress achieved in the past decade, this represents a significant milestone in the quest for healthier aging. It stands as a testament to the tireless efforts of scientists and researchers dedicated to unraveling the secrets of longevity. By sharing these groundbreaking interventions with the world, we hope to empower individuals and inspire a new era of healthy living. 


About Deep Longevity:- 
Deep Longevity developed the Longevity as a Service (LaaS)© solution to integrate multiple deep biomarkers of aging dubbed “deep aging clocks” to provide a universal multifactorial measure of human biological age. Deep Longevity is owned by Hong Kong Stock Exchange listed Endurance Longevity SEHK:0575. Visit - https://www.deeplongevity.com/ 

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.